Bilcare (526853.BO) Stock Price

Bilcare Price

CLOSED
95.90
​
Market closed

Revenue has compounded at 2.8% per year over the past 19 years to 7.23 B INR. Earnings per share have declined at 19.3% per year over the last 19 years. Bilcare's net margin stands at 0.2%, up from -1.5% several years earlier. Bilcare currently offers a dividend yield of about 2.09%. The payout ratio is around 4% of earnings.

Bilcare stock price

Access this data via the Eulerpool API

Bilcare business model & stock analysis

Bilcare Ltd. is a holding company, which engages in the provision of pharma packaging research solutions. The company is headquartered in Pune, Maharashtra and currently employs 70 full-time employees. The firm is involved in the business of pharmaceutical packaging, global clinical services, research and development (R&D) services and anti-counterfeit technology (nCid). The firm offers a range of specialty polymer films and aluminum foils mainly used for packaging of solid-dosage pharmaceutical products. The company handles domestic and global manufacturing of investigational medicinal products (IMPs) and placebos, primary and secondary packaging with various blinding techniques, interactive Web response systems (IWRS), storage at variable temperatures along with distribution on global depots/sites, which have approximately 30+ depots spread worldwide. The firm's manufacturing plant is located in Pune, India. The firm has operations in India, Singapore, Germany, and the United States.

Frequently asked questions about Bilcare

Converted at the current exchange rate, the Bilcare share trades at 0.89 EUR (95.90 INR).

The revenue of Bilcare is 7.23 B INR. This figure is based on current financial data and reflects the company's business performance.

The profit of Bilcare is 17.28 M INR. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Bilcare is currently 130.64. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Bilcare stock.

The price-to-sales ratio (P/S) of Bilcare is currently 0.31. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Bilcare stock.

The Eulerpool Quality Score for Bilcare is 1/10.

The ISIN of Bilcare is INE986A01012. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Bilcare is 526853.BO. The ticker symbol is used to trade Bilcare shares on the stock exchange.

Fair ValueTerminal
82.47 INR
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Life Sciences Tools & Services
Number of shares
Employees
Revenue per Employee
103.22 M INR
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Website bilcare.com
Country
Currency
INR
Initial public offering
Apr 25, 1995
ISIN
INE986A01012
Cusip
Y0889B112
Market capitalization
2.26 B INRMid Cap
52-Week Range
PEG
—
P/E ratio
P/Ee
—
P/S
P/Se
—
EV/EBIT
20.17
P/B Ratio
1.15
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
0.27 %
Dividend
Dividend yield
0.00 %
Payout Ratio
4.22 %
Dividend growth Ø5Y
-12.94 %
Dividend payments per year
1
Dividend paid since
0 years
Dividend not reduced since
0 years
Dividend increased since
0 years
Dividend withholding tax
20.00 %
Last updated Oct 9, 2026, 8:21 AM

Bilcare Peer Group

Bilcare FIGI

BILC:IN · BBG000CBL3X5BILC:IB · BBG000CBL454BILC:IG · BBG003NVVLW3

All fundamentals and in-depth analysis of Bilcare

Our stock analysis for Bilcare stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Bilcare. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.